Overexpression of Metastatic Related MicroRNAs, Mir-335 and Mir-10b, by Staphylococcal Enterotoxin B in the Metastatic Breast Cancer Cell Line

Mohammad Foad Heidary ¹, Hamideh Mahmoodzadeh Hosseini ², Elnaz Mehdizadeh Aghdam ³, Mohammad Reza Nourani, Reza Ranjbar, Reza Mirnejad, Abbas Ali Imani Fooladi ² *

Cited by CrossRef: 15

1- Luo L, Wang D, Wang J, Yang F, Tang J. Diverse roles of miR-335 in development and progression of cancers. Tumor Biol. 2016;37(12):15399 [Crossref]

2- Liu T, Li L, Yin L, Yu H, Jing H, Liu Y, Kong C, Xu M. Superantigen staphylococcal enterotoxin C1 inhibits the growth of bladder cancer. 2017;81(9):1741 [Crossref]

3- Moein S, Vaghari‐Tabari M, Qujeq D, Majidinia M, Nabavi S, Yousefi B. MiRNAs and inflammatory bowel disease: An interesting new story. Journal Cellular Physiology. 2019;234(4):3277 [Crossref]

4- Zhang Y, Han T, Feng D, Li J, Wu M, Peng X, Wang B, Zhan X, Fu P. Screening of non-invasive miRNA biomarker candidates for metastasis of gastric cancer by small RNA sequencing of plasma exosomes. 2020;41(5):582 [Crossref]

5- Jadideslam G, Ansarin K, Sakhinia E, Babaloo Z, Abhari A, Ghahremanzadeh K, Khalili M, Radmehr R, Kabbazi A. Diagnostic biomarker and therapeutic target applications of miR‐326 in cancers: A systematic review. Journal Cellular Physiology. 2019;234(12):21560 [Crossref]

6- Xie Y, Deng H, Wei R, Sun W, Qi Y, Yao S, Cai L, Wang Y, Deng Z. Overexpression of miR-335 inhibits the migration and invasion of osteosarcoma by targeting SNIP1. International Journal of Biological Macromolecules. 2019;133:137 [Crossref]

7- Wang Y, Chen X, Ma R, Gao P. Understanding the CREB1-miRNA feedback loop in human malignancies. Tumor Biol. 2016;37(7):8487 [Crossref]

8- Duarte A, Montagna D, Pastorini M, Alemán M. Apoptosis-mediated inhibition of human T-cell acute lymphoblastic leukemia upon treatment with Staphylococus Aureus enterotoxin-superantigen. Front Immunol. 2023;14 [Crossref]

9- Deacy A, Gan S, Derrick J. Superantigen Recognition and Interactions: Functions, Mechanisms and Applications. Front Immunol. 2021;12 [Crossref]

10- Ranjbar R, Karimian A, Aghaie Fard A, Tourani M, Majidinia M, Jadidi‐Niaragh F, Yousefi B. The importance of miRNAs and epigenetics in acute lymphoblastic leukemia prognosis. Journal Cellular Physiology. 2019;234(4):3216 [Crossref]

11- Ranjbar R, Behjatfar M, Teimouri A, Aghaie Fard A, Maniati M, Taheri‐Anganeh M. Long non‐coding RNAs and microorganism‐associated cancers. Cell Biochemistry & Function. 2021;39(7):844 [Crossref]

12- Wang Y, Wang H, Ding Y, Li Y, Chen S, Zhang L, Wu H, Zhou J, Duan K, Wang W, Chen C, Yang Q. N-peptide of vMIP-II reverses paclitaxel-resistance by regulating miRNA-335 in breast cancer. 2017;51(3):918 [Crossref]

13- Pudova E, Krasnov G, Nyushko K, Kobelyatskaya A, Savvateeva M, Poloznikov A, Dolotkazin D, Klimina K, Guvatova Z, Simanovsky S, Gladysh N, Tokarev A, Melnikova N, Dmitriev A, Alekseev B, Kaprin A, Kiseleva M, Snezhkina A, Kudryavtseva A. miRNAs expression signature potentially associated with lymphatic dissemination in locally advanced prostate cancer. BMC Med Genomics. 2020;13(S8) [Crossref]

14- Nikolova E, Georgiev C, Laleva L, Milev M, Spiriev T, Stoyanov S, Taseva-Mineva T, Mitev V, Todorova A. Diagnostic, grading and prognostic role of a restricted miRNAs signature in primary and metastatic brain tumours. Discussion on their therapeutic perspectives. Mol Genet Genomics. 2022;297(2):357 [Crossref]

15- Majidinia M, Darband S, Kaviani M, Nabavi S, Jahanban-Esfahlan R, Yousefi B. Cross-regulation between Notch signaling pathway and miRNA machinery in cancer. DNA Repair. 2018;66-67:30 [Crossref]